Accelerated Pharma (Accelerated Pharma) Accounts Payable : $0.91 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Accounts Payable?

Accelerated Pharma's Accounts Payable for the quarter that ended in Mar. 2017 was $0.91 Mil.

Accelerated Pharma's quarterly Accounts Payable increased from Sep. 2016 ($0.87 Mil) to Dec. 2016 ($0.88 Mil) and increased from Dec. 2016 ($0.88 Mil) to Mar. 2017 ($0.91 Mil).

Accelerated Pharma's annual Accounts Payable increased from Dec. 2014 ($0.00 Mil) to Dec. 2015 ($0.60 Mil) and increased from Dec. 2015 ($0.60 Mil) to Dec. 2016 ($0.88 Mil).

Accelerated Pharma Accounts Payable Historical Data

The historical data trend for Accelerated Pharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Accounts Payable Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Accounts Payable

0.60

0.88

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Accounts Payable	Get a 7-Day Free Trial			-	0.84	0.87	0.88	0.91

Accelerated Pharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Accelerated Pharma Accounts Payable Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines